|
| << previous | next >> |
Journal description
All volumes of the corresponding journal
All issues of the corresponding volume
All articles of the corresponding issues
Details for article 62 of 278 found articles
| Title: |
PCN40 COST OF MANAGING ADVERSE EVENTS IN THE TREATMENT OF FIRST LINE METASTASIC RENAL CELL CARCINOMA: BEVACIZUMAB + INTERFERON ALPHA-2A COMPARED WITH SUNITINIB IN SPAIN |
| Author: |
Calderero, V García-Muro, X Puente, J Trigo, JM Castro, AJ Martín-Escudero, V Yébenes, M Casado, MA |
| Appeared in: |
Value in health |
| Paging: | Volume 12 (2009) nr. 7 pages 1 p. |
| Year: |
2009 |
| Contents: | |
| Publisher: |
International Society for Pharmacoeconomics and Outcomes Research (ISPOR) |
| Source file: |
Elektronische Wetenschappelijke Tijdschriften |
Details for article 62 of 278 found articles
| << previous | next >> |